- Association of a SLC30A8 Genetic Variant with Monotherapy of Repaglinide and Rosiglitazone Effect in Newly Diagnosed Type 2 Diabetes Patients in China. Jiang, F., Li, Q., Hu, C., Zhang, R., Wang, C.R., Yu, W.H., Lu, J.Y., Tang, S.S., Bao, Y.Q., Xiang, K.S., Jia, W.P. Biomed. Environ. Sci. (2012)